BioStem Technologies, Inc. (BSEM)
5.21
-0.28
(-5.10%)
USD |
OTCM |
Mar 06, 15:59
BioStem Technologies Cash from Investing (TTM) : -1.796M for Sept. 30, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Plus Therapeutics, Inc. | 0.287M |
| Iovance Biotherapeutics, Inc. | 47.50M |
| Protokinetix, Inc. | -0.0414M |
| GB Sciences, Inc. | 0.00 |
| Travere Therapeutics, Inc. | 27.89M |